{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:42:08Z","timestamp":1779918128168,"version":"3.53.1"},"reference-count":171,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013228","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T13:01:12Z","timestamp":1545051672000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus"],"prefix":"10.1002","author":[{"given":"Birgit","family":"Fullerton","sequence":"first","affiliation":[{"name":"Goethe University; Institute of General Practice; Theodor-Stern-Kai 7 Frankfurt am Main Hesse Germany 60590"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Siebenhofer","sequence":"additional","affiliation":[{"name":"Graz, Austria \/ Institute of General Practice, Goethe University; Institute of General Practice and Evidence-Based Health Services Research, Medical University of Graz; Frankfurt am Main Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Jeitler","sequence":"additional","affiliation":[{"name":"Medical University of Graz; Institute of General Practice and Evidence-Based Health Services Research \/ Institute for Medical Informatics, Statistics and Documentation; Auenbruggerplatz 2\/9 Graz Austria 8036"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Horvath","sequence":"additional","affiliation":[{"name":"Medical University of Graz; Institute of General Practice and Evidence-Based Health Services Research \/ Department of Internal Medicine, Division of Endocrinology and Metabolism; Auenbruggerplatz 2\/9 Graz Austria 8036"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Semlitsch","sequence":"additional","affiliation":[{"name":"Medical University of Graz; Institute of General Practice and Evidence-Based Health Services Research; Auenbruggerplatz 2\/9 Graz Austria 8036"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Berghold","sequence":"additional","affiliation":[{"name":"Medical University of Graz; Institute for Medical Informatics, Statistics and Documentation; Auenbruggerplatz 2 Graz Austria 8036"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand M","family":"Gerlach","sequence":"additional","affiliation":[{"name":"Goethe University; Institute of General Practice; Theodor-Stern-Kai 7 Frankfurt am Main Hesse Germany 60590"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1463-1326.2003.00283.x","article-title":"Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure","volume":"5","author":"Altuntas","year":"2003","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD013228-BIB0002|cit2","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1463-1326.2000.00066.x","article-title":"Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin Lispro","volume":"2","author":"Bastyr","year":"2000","journal-title":"Diabetes Obesity and Metabolism"},{"key":"10.1002\/14651858.CD013228-BIB0004|cit4","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"10","key":"10.1002\/14651858.CD013228-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/diacare.27.10.2363","article-title":"Insulin Glulisine provides improved glycemic control in patients with type 2 diabetes","volume":"27","author":"Dailey","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0006|cit6","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0033-1334905","article-title":"Comparison of insulin Aspart vs. regular human insulin with or without insulin Detemir concerning adipozytokines and metabolic effects in patients with type 2 diabetes mellitus","volume":"121","author":"Hermann","year":"2013","journal-title":"Experimental & Clinical Endocrinology & Diabetes"},{"key":"10.1002\/14651858.CD013228-BIB0008|cit8","unstructured":"NCT01650129 Safety and efficacy of biphasic insulin Aspart 50 in subjects with type 2 diabetes clinicaltrials.gov\/ct2\/show\/NCT01650129"},{"key":"10.1002\/14651858.CD013228-BIB0009|cit9","unstructured":"Novo Nordisk An open-labelled randomised, parallel group, multicentre, safety and efficacy study of NN-X14Mix50 (BIAsp50) in a twice daily regimen in type 2 diabetic subjects novonordisk-trials.com"},{"key":"10.1002\/14651858.CD013228-BIB0010|cit10","unstructured":"EudraCT2011-003733-34 Human insulin analogs: evaluation of inflammatory mRNA expression of macrophages and endothelial function of short-acting insulin - HERMES pilot study www.clinicaltrialsregister.eu\/ctr-search\/trial\/2011-003733-34\/DE"},{"key":"10.1002\/14651858.CD013228-BIB0011|cit11","unstructured":"NCT01417897 Human insulin analogs: evaluation of inflammatory mRNA expression of macrophages and endothelial function of short-acting insulin - HERMES pilot study (HERMES) clinicaltrials.gov\/ct2\/show\/NCT01417897"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD013228-BIB0012|cit12","first-page":"A235","article-title":"Impact of short-acting insulin analogs on biomarkers of oxidative stress and chronic systemic inflammation in patients with type 2 diabetes: results from a pilot study","volume":"62","author":"Pf\u00fctzner","year":"2013","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD013228-BIB0013|cit13","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.diabres.2006.09.006","article-title":"Insulin Glulisine imparts effective glycaemic control in patients with type 2 diabetes","volume":"76","author":"Rayman","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD013228-BIB0015|cit15","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0016|cit16","first-page":"292","article-title":"A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents","volume":"24","author":"Ross","year":"2001","journal-title":"Clinical and Investigative Medicine. Medecine Clinique et Experimentale"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0149-2918(97)80073-2","article-title":"Improved mealtime treatment of diabetes mellitus using an insulin analogue","volume":"19","author":"Anderson","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD013228-BIB0018|cit18","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0149-2918(97)80073-2","article-title":"Improved mealtime treatment of diabetes mellitus using an insulin analogue","volume":"19","author":"Anderson","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD013228-BIB0020|cit20","unstructured":"IQWiG (Institute for Quality and Efficiency in Health Care) Short-acting insulin analogues in the treatment of diabetes mellitus type 2 Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2005 December. Abschlusbericht A05-04"},{"issue":"19","key":"10.1002\/14651858.CD013228-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1097\/00029330-200710010-00012","article-title":"A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients","volume":"120","author":"Bi","year":"2007","journal-title":"Chinese Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD013228-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2004.10.001","article-title":"Long-term efficacy and safety of biphasic insulin Aspart in patients with type 2 diabetes","volume":"15","author":"Boehm","year":"2004","journal-title":"European Journal of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013228-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/diacare.22.12.2089a","article-title":"Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial","volume":"22","author":"Boivin","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"626-34","DOI":"10.1046\/j.1464-5491.2003.01010.x","article-title":"Effect of the rapid-acting insulin analogue insulin Aspart on quality of life and treatment satisfaction in patients with type 1 diabetes","volume":"20","author":"Bott","year":"2003","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0026-0495(98)90045-2","article-title":"Effects of a short-acting insulin analog (insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus","volume":"47","author":"Caix\u00e0s","year":"1998","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"9","key":"10.1002\/14651858.CD013228-BIB0026|cit26","first-page":"1404","article-title":"Effect of insulin Lispro on glycaemic control in Chinese diabetic patients receiving twice-daily regimens of insulin","volume":"117","author":"Chan","year":"2004","journal-title":"Chinese Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD013228-BIB0027|cit27","first-page":"827","article-title":"Comparison on the efficacy of biphasic insulin Aspart 30 and premixed human insulin 30\/70 through continuous glucose monitoring system","volume":"32","author":"Chen","year":"2011","journal-title":"Chung-Hua Liu Hsing Ping Hsueh Tsa Chih (Chinese Journal of Epidemiology)"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5507\/bp.2004.004","article-title":"Benefits of insulin Aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump","volume":"148","author":"Chlup","year":"2004","journal-title":"Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, Czech Republic"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0029|cit29","first-page":"29","article-title":"Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy","volume":"10","author":"Cypryk","year":"2004","journal-title":"Medical Science Monitor"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/dmrr.202","article-title":"Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin Lispro and regular human insulin","volume":"17","author":"Ferguson","year":"2001","journal-title":"Diabetes\/metabolism Research and Reviews"},{"issue":"12","key":"10.1002\/14651858.CD013228-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/diab.45.12.1750","article-title":"Immunologic effects of insulin lispro (Lys (B28), Pro (B29) human insulin) in IDDM and NIDDM patients previously treated with insulin","volume":"45","author":"Fineberg","year":"1996","journal-title":"Diabetes"},{"issue":"28","key":"10.1002\/14651858.CD013228-BIB0032|cit32","first-page":"1960","article-title":"Postprandial glycemic control using insulin Aspart with NPH in inadequately controlled diabetics","volume":"89","author":"Gao","year":"2009","journal-title":"Chung-Hua i Hsueh Tsa Chih (Chinese Medical Journal)"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1096-9136(199601)13:1<47::AID-DIA999>3.0.CO;2-M","article-title":"Pre-meal insulin analogue insulin Lispro vs humulin insulin treatment in young subjects with type 1 diabetes","volume":"13","author":"Garg","year":"1996","journal-title":"Diabetic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1463-1326.2000.00108.x","article-title":"Impact of insulin Lispro on HbA1c values in insulin pump users","volume":"2","author":"Garg","year":"2000","journal-title":"Diabetes Obesity and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2337\/dc10-0531","article-title":"Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish diabetes study","volume":"34","author":"Gram","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1016\/S0300-2977(97)87106-9","article-title":"Pre-meal therapy with Lispro insulin and regular insulin in IDDM patients","volume":"50","author":"Holleman","year":"1997","journal-title":"The Netherlands Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013228-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-5491.2000.00380.x","article-title":"Insulin Aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial","volume":"17","author":"Home","year":"2000","journal-title":"Diabetic Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.diabres.2005.05.015","article-title":"Pre-meal insulin Aspart compared with pre-meal soluble human insulin in type 1 diabetes","volume":"71","author":"Home","year":"2006","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"11","key":"10.1002\/14651858.CD013228-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2337\/diacare.27.11.2739","article-title":"Effects of mixing Glargine and short-acting insulin analogs on glucose control","volume":"27","author":"Kaplan","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.22.3.468","article-title":"Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog Lispro in variable combination with NPH insulin at mealtime","volume":"22","author":"Lalli","year":"1999","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0041|cit41","first-page":"273","article-title":"Experience with Lispro-insulin in the intensified therapy of IDDM and NIDDM patients","volume":"5","author":"Laube","year":"1996","journal-title":"Diabetes und Stoffwechsel"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diacare.22.5.801","article-title":"Improved postprandial glycemic control with insulin Aspart. A randomized double-blind cross-over trial in type 1 diabetes","volume":"22","author":"Lindholm","year":"1999","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diacare.25.5.876","article-title":"Immune responses to insulin Aspart and biphasic insulin Aspart in people with type 1 and type 2 diabetes","volume":"25","author":"Lindholm","year":"2002","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2337\/diacare.26.4.1193","article-title":"Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro","volume":"26","author":"Loukovaara","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12902-016-0102-1","article-title":"Systematic literature review of use of blood glucose monitoring in phase III clinical studies of insulin analogs","volume":"16","author":"Miikkulainen","year":"2016","journal-title":"BMC Endocrine Disorders"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00592-011-0320-y","article-title":"Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index)","volume":"50","author":"P\u00e9rez-Maraver","year":"2013","journal-title":"Acta Diabetologica"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1464-5491.2005.01473.x","article-title":"Insulin Aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial","volume":"22","author":"Perriello","year":"2005","journal-title":"Diabetic Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8227(02)00141-9","article-title":"Insulin Lispro therapy in pregnancies complicated by type 1 diabetes mellitus","volume":"58","author":"Persson","year":"2002","journal-title":"Diabetes Research & Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0049|cit49","first-page":"133","article-title":"Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: A randomized, cross-over comparative study with regular insulin","volume":"14","author":"Provenzano","year":"2001","journal-title":"Diabetes, Nutrition & Metabolism"},{"issue":"11","key":"10.1002\/14651858.CD013228-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s004310050724","article-title":"Postprandial glycaemia after regular and Lispro insulin in children and adolescents with diabetes","volume":"156","author":"Rami","year":"1997","journal-title":"European Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.23.5.583","article-title":"Use of insulin Aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes","volume":"23","author":"Raskin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0168-8227(03)00036-6","article-title":"Insulin Lispro is as effective as regular insulin in optimising metabolic control and preserving \u00df-cell function at onset of type 1 diabetes mellitus","volume":"60","author":"Recasens","year":"2003","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1742-1241.2001.tb11010.x","article-title":"Improved glycemic control with the use of self-prepared mixtures of insulin Lispro and insulin Lispro protamine suspension in patients with types 1 and 2 diabetes","volume":"55","author":"Roach","year":"2001","journal-title":"International Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-2004-814345","article-title":"Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30\/70","volume":"36","author":"Schernthaner","year":"2004","journal-title":"Hormone and Metabolic Research"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0055|cit55","first-page":"15","article-title":"Insulin Lispro improves postprandial glucose control in patients with diabetes mellitus","volume":"103","author":"Skrha","year":"2002","journal-title":"Sbornik Lekarsky"},{"key":"10.1002\/14651858.CD013228-BIB0056|cit56","first-page":"58","article-title":"Lispro analog and quality of life","volume":"3","author":"Tubiana-Rufi","year":"1997","journal-title":"Diabetes & Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0149-2918(97)80014-8","article-title":"Efficacy of insulin Lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin dependent diabetes mellitus. Multicenter Iinsulin Lispro Study Group","volume":"19","author":"Vignati","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD013228-BIB0058|cit58","unstructured":"Yanagisawa K Yamagishi S Ashihara J Obara S Wada N Evaluation of efficacy, safety and QOL of glulisine on Japanese type 1 diabetes Diabetes 2013 A654 (2574-PO)"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12902-016-0116-8","article-title":"Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study","volume":"16","author":"Farshchi","year":"2016","journal-title":"BMC Endocrine Disorders"},{"key":"10.1002\/14651858.CD013228-BIB0060|cit60","unstructured":"NCT01889095 Biphasic insulin Aspart versus NPH plus regular human insulin in type 2 diabetic patients clinicaltrials.gov\/ct2\/show\/NCT01889095"},{"key":"10.1002\/14651858.CD013228-BIB0061|cit61","unstructured":"NCT01500850 Establishing cardiovascular biomarkers to define preferred Lantus \u00ae use clinicaltrials.gov\/ct2\/show\/NCT01500850"},{"key":"10.1002\/14651858.CD013228-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"The Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","author":"American Diabetes Association (ADA)","year":"1997","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013228-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","journal-title":"Diabetes Care"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD013228-BIB0065|cit65","first-page":"S 11-33","article-title":"Standards of medical care in diabetes - 2017","volume":"40","author":"American Diabetes Association (ADA)","year":"2017","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013228-BIB0066|cit66","first-page":"S1","article-title":"Standards of medical care in diabetes - 2018","volume":"41","author":"American Diabetes Association (ADA)","year":"2018","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1002\/14651858.CD013228-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"The ADVANCE Collaborative Group","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD013228-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/archinte.168.19.2088","article-title":"National trends in treatment of type 2 diabetes mellitus","volume":"168","author":"Alexander","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"7382","key":"10.1002\/14651858.CD013228-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0149-2918(97)80073-2","article-title":"Improved mealtime treatment of diabetes mellitus using an insulin analogue","volume":"19","author":"Anderson","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD013228-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"285-92","DOI":"10.1111\/j.1464-5491.2005.01781.x","article-title":"Improved glycaemic control with insulin Glargine plus insulin Lispro: a multicentre, randomized, cross-over trial in people with type 1 diabetes","volume":"23","author":"Ashwell","year":"2006","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0072|cit72","unstructured":"Banerjee S Tran K Li H Cimon K Daneman D Simpson S Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness Ottawa (ON); Canadian Agency for Drugs and Technologies in Health; 2007. Technology Report no 87"},{"key":"10.1002\/14651858.CD013228-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/pon.3205","article-title":"Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures","volume":"22","author":"Bell","year":"2013","journal-title":"Psycho-oncology"},{"key":"10.1002\/14651858.CD013228-BIB0074|cit74","first-page":"37","article-title":"Classification and diagnosis of diabetes mellitus","volume-title":"Textbook of Diabetes","author":"Bennett","year":"1991"},{"key":"10.1002\/14651858.CD013228-BIB0075|cit75","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-87912-8","volume-title":"Insulintherapie in der Praxis","author":"Berger","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I\u00b2 is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013228-BIB0077|cit77","unstructured":"Borenstein M Prediction intervals www.meta-analysis.com\/prediction"},{"issue":"36","key":"10.1002\/14651858.CD013228-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2014.56.7503","article-title":"Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial","volume":"32","author":"Boutron","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1464-5491.2000.00289.x","article-title":"Post-prandial administration of the insulin analogue insulin Aspart in patients with type 1 diabetes mellitus","volume":"17","author":"Brunner","year":"2000","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1503\/cmaj.081180","article-title":"Cost-effectiveness of insulin analogues for diabetes mellitus","volume":"180","author":"Cameron","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"813-9","DOI":"10.1210\/jc.2005-1005","article-title":"Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study","volume":"91","author":"Cavalot","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD013228-BIB0082|cit82","unstructured":"CENTRAL creation details www.cochranelibrary.com\/central\/central-creation"},{"key":"10.1002\/14651858.CD013228-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"d5782","DOI":"10.1136\/bmj.d5782","article-title":"The prickly problem of access to insulin","volume":"343","author":"Cohen","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jrsm.1090","article-title":"Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool","volume":"5","author":"Corbett","year":"2014","journal-title":"Research Synthesis Methods"},{"issue":"8","key":"10.1002\/14651858.CD013228-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.clinthera.2009.08.011","article-title":"Risk for nocturnal hypoglycemia with biphasic insulin Aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis","volume":"31","author":"Davidson","year":"2009","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc13-2915","article-title":"Insulin analogs-Is there a compelling case to use them? No!","volume":"37","author":"Davdison","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.11.9.725","article-title":"Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT)","volume":"11","author":"The DCCT Research Group","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group (DCCT)","year":"1993","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0089|cit89","unstructured":"Deeks JJ Higgins JPT Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2288-14-49","article-title":"Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study","volume":"14","author":"Egbewale","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013228-BIB0092|cit92","unstructured":"European Medicines Agency Note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus www.emea.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003262.pdf 2002"},{"issue":"8","key":"10.1002\/14651858.CD013228-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2337\/dc11-0182","article-title":"Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology","volume":"34","author":"Engwerda","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00125-007-0922-7","article-title":"Modern insulins - comment on facts and assumptions in a recent editorial","volume":"51","author":"Frick","year":"2008","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD013228-BIB0095|cit95","first-page":"d5675","article-title":"Commentary: politics of affordable insulin","volume":"343","author":"Gale","year":"2011","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD013228-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"e4611","DOI":"10.1136\/bmj.e461","article-title":"Newer insulins in type 2 diabetes","volume":"345","author":"Gale","year":"2012","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD013228-BIB0097|cit97","volume-title":"Evidence-based Diabetes Care","author":"Gerstein","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00044011-200828040-00001","article-title":"Defining the role of insulin Lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus","volume":"28","author":"Giugliano","year":"2008","journal-title":"Clinical Drug Investigation"},{"issue":"11","key":"10.1002\/14651858.CD013228-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2006.10.015","article-title":"A review of human and analogue insulin trials","volume":"77","author":"Gough","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD013228-BIB0100|cit100","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD013228-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00400229","article-title":"Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor","volume":"36","author":"Grant","year":"1993","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/dc14-0031","article-title":"Insulin analogs-are they worth it? Yes!","volume":"37","author":"Grunberger","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/edrv.19.5.0343","article-title":"The importance of hyperglycemia in the non-fasting state to the development of cardiovascular disease","volume":"19","author":"Haffner","year":"1998","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD013228-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"d7202","DOI":"10.1136\/bmj.d7202","article-title":"Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses","volume":"344","author":"Hart","year":"2012","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD013228-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/(SICI)1096-9136(199607)13:7<683::AID-DIA144>3.0.CO;2-1","article-title":"Time-action profile of the insulin analogue B28Asp","volume":"13","author":"Heinemann","year":"1996","journal-title":"Diabetic Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013228-BIB0106|cit106","first-page":"A34","article-title":"Faster-acting insulin Aspart improves postprandial glycaemia versus insulin Aspart in patients with type 1 diabetes mellitus","volume":"63","author":"Heise","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00125-004-1365-z","article-title":"Insulin analogues (insulin Detemir and insulin Aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes","volume":"47","author":"Hermansen","year":"2004","journal-title":"Diabetologia"},{"issue":"11","key":"10.1002\/14651858.CD013228-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1185\/03007990903262885","article-title":"Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study","volume":"25","author":"Hermansen","year":"2009","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD013228-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed.)"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"Journal of the Royal Statistical Society: Series A (Statistics in Society)"},{"key":"10.1002\/14651858.CD013228-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD013228-BIB0113|cit113","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"e000258","DOI":"10.1136\/bmjopen-2011-000258","article-title":"Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin","volume":"1","author":"Holden","year":"2011","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD013228-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1783-90","DOI":"10.1007\/s00125-007-0763-4","article-title":"Nice insulins, pity about the evidence","volume":"50","author":"Holleman","year":"2007","journal-title":"Diabetologia"},{"issue":"9","key":"10.1002\/14651858.CD013228-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","article-title":"The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences","volume":"14","author":"Home","year":"2012","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD013228-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2337\/diab.43.3.396","article-title":"(Lys(B28), Pro(B29))-human insulin. A rapidly absorbed analogue of human insulin","volume":"43","author":"Howey","year":"1994","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD013228-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hr\u00f3bjartsson","year":"2013","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD013228-BIB0120|cit120","unstructured":"Institute for Quality and Efficiency in Health Care Short acting insulin analogues for the treatment of type 2 diabetes mellitus www.iqwig.de\/download\/A05-04_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Typ_2_Diabetes_mellitus.pdf"},{"key":"10.1002\/14651858.CD013228-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12916-015-0520-3","article-title":"Comparison of registered and published outcomes in randomized controlled trials: a systematic review","volume":"13","author":"Jones","year":"2015","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0122|cit122","first-page":"A3","article-title":"Carciogen effect of the human insulin analogue B10 Asp in female rats","volume":"35 Suppl 1","author":"J\u00f8rgensen","year":"1992","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD013228-BIB0123|cit123","unstructured":"Kaye J Krasner A Canney L Pichotta P Simms P Krishnarajah J Novel formulations BIOD-238 and BIOD-250 result in more rapid absorption and declines from peak than Humalog 49th Annual Meeting of the European Association for the Study of Diabetes Barcelona, Spain EASD 2013 56 S413"},{"key":"10.1002\/14651858.CD013228-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1172\/JCI111764","article-title":"Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta","volume":"75","author":"King","year":"1985","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD013228-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ (Clinical research ed.)"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/193229681200600408","article-title":"A review of a family of ultra-rapid-acting insulins: formulation development","volume":"6","author":"Krasner","year":"2012","journal-title":"Journal of Diabetes Science and Technology"},{"key":"10.1002\/14651858.CD013228-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","article-title":"Correlation of receptor binding and metabolic and metogenic potencies of insulin analogues designed for clinical use","volume":"49","author":"Kurtzhals","year":"2000","journal-title":"Diabetes"},{"issue":"8","key":"10.1002\/14651858.CD013228-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/dmrr.2536","article-title":"Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device","volume":"30","author":"Landau","year":"2014","journal-title":"Diabetes\/metabolism Research and Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013228-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013228-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2008.00934.x","article-title":"Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis","volume":"11","author":"Mannucci","year":"2009","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD013228-BIB0131|cit131","volume-title":"The Diabetes Annual 12","author":"Marshall","year":"1999"},{"key":"10.1002\/14651858.CD013228-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2009.1242","article-title":"Comparison of registered and published primary outcomes in randomized controlled trials","volume":"302","author":"Mathieu","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013228-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-3-82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"3","author":"Meader","year":"2014","journal-title":"Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12020-012-9817-6","article-title":"Insulin therapy for type 2 diabetes","volume":"43","author":"Meneghini","year":"2013","journal-title":"Endocrine"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01059088","article-title":"Modeling absorption kinetics of subcutaneous injected soluble insulin","volume":"17","author":"Mosekilde","year":"1989","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"10.1002\/14651858.CD013228-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s001250051065","article-title":"Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes - a prospective population based study","volume":"41","author":"Muehlhauser","year":"1998","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD013228-BIB0137|cit137","unstructured":"National Collaborating Centre for Chronic Conditions (UK) Type 2 diabetes: National Clinical Guideline for management in primary and secondary care (update) London: Royal College of Physicians (UK); 2008. NICE Clinical Guidelines, No. 66"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"256","author":"Nissen","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-5448.2008.00472.x","article-title":"Good glycaemic control remains crucial in prevention of late diabetic complication - the Link\u00f6ping Diabetes Complication Study","volume":"10","author":"Nordwall","year":"2009","journal-title":"Pediatric Diabetes"},{"key":"10.1002\/14651858.CD013228-BIB0140|cit140","unstructured":"Bundes\u00e4rztekammer Kassen\u00e4rztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften Berlin: \u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin; 2013"},{"key":"10.1002\/14651858.CD013228-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-8227(98)00132-6","article-title":"Injection-meal interval: recommendations of diabetologists and how patients handle it","volume":"43","author":"Overmann","year":"1999","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/diaclin.20.2.71","article-title":"Is postprandial glucose control important? Is it practical in primary care settings?","volume":"20","author":"Parkin","year":"2002","journal-title":"Clinical Diabetes"},{"issue":"10","key":"10.1002\/14651858.CD013228-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1185\/03007995.2014.933098","article-title":"Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control","volume":"30","author":"Pf\u00fctzner","year":"2014","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabres.2004.03.003","article-title":"Insulin Detemir and insulin Aspart: a promising basal-bolus regimen for type 2 diabetes","volume":"66","author":"Raslov\u00e1","year":"2004","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0033-1363684","article-title":"Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis","volume":"122","author":"Rathmann","year":"2014","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1002\/14651858.CD013228-BIB0146|cit146","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD013228-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"16","key":"10.1002\/14651858.CD013228-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/sim.5726","article-title":"Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data","volume":"32","author":"Riley","year":"2013","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013228-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.diabet.2010.12.003","article-title":"Efficacy and safety comparison of rapid-acting insulin Aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review","volume":"37","author":"Rys","year":"2011","journal-title":"Diabetes & Metabolism"},{"key":"10.1002\/14651858.CD013228-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"d5858","DOI":"10.1136\/bmj.d5858","article-title":"Commentary: does additional benefit justify additional costs of insulin analogues?","volume":"343","author":"Sawicki","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diacare.21.4.570","article-title":"Postprandial insulin lispro: a new therapeutic option for type 1 diabetic patients","volume":"21","author":"Schernthaner","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0152|cit152","doi-asserted-by":"crossref","unstructured":"Schroll JB Bero L Regulatory agencies hold the key to improving Cochrane Reviews of drugs Cochrane Database of Systematic Reviews 2015 10.1002\/14651858.ED000098","DOI":"10.1002\/14651858.ED000098"},{"key":"10.1002\/14651858.CD013228-BIB0153|cit153","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"21","key":"10.1002\/14651858.CD013228-BIB0154|cit154","first-page":"1","article-title":"Insulin analogs and cancer","volume":"3","author":"Sciacca","year":"2012","journal-title":"Frontiers in Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD013228-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.2337\/diacare.28.11.2806","article-title":"Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients","volume":"28","author":"Shiraiwa","year":"2005","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD013228-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jama.298.10.1189","article-title":"Longterm risk of cardiovascular events with rosiglitazone: a meta-analysis","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.081041","article-title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis","volume":"180","author":"Singh","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"9","key":"10.1002\/14651858.CD013228-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00125-009-1441-5","article-title":"Does diabetes therapy influence the risk of cancer?","volume":"52","author":"Smith","year":"2009","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013228-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.2337\/dc11-s206","article-title":"Postprandial hyperglycemia and glycemic variability: should we care?","volume":"34","author":"Standl","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD013228-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013228-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD013228-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF00417697","article-title":"Pharmacokinetics, pharmacodynamics and glucose counter-regulation following subcutaneous injection of the monomeric insulin analogue (Lys(B28), Pro(B29)) in IDDM","volume":"37","author":"Torlone","year":"1994","journal-title":"Diabetologia"},{"issue":"9131","key":"10.1002\/14651858.CD013228-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013228-BIB0164|cit164","first-page":"1","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications","volume-title":"Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus","author":"World Health Organization","year":"1999"},{"key":"10.1002\/14651858.CD013228-BIB0165|cit165","unstructured":"World Health Organization Review of the evidence comparing insulin (human or animal) with analogue insulins 18th Expert Committee on the Selection and Use of Essential Medicines; 2011 March 21-25; Accra, Ghana World Health Organization 2011"},{"issue":"5","key":"10.1002\/14651858.CD013228-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD013228-BIB0167|cit167","first-page":"451","article-title":"Comparison of top-performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"1","key":"10.1002\/14651858.CD013228-BIB0168|cit168","first-page":"41","article-title":"Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"7644","key":"10.1002\/14651858.CD013228-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD013228-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM198908103210605","article-title":"The physiological replacement of insulin: an elusive goal","volume":"321","author":"Zinman","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013228-BIB0171|cit171","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003287.pub4","article-title":"Short acting insulin analogues versus regular human insulin inpatients with diabetes mellitus","author":"Siebenhofer","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013228\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T06:45:12Z","timestamp":1694501112000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD013228"}},"subtitle":[],"editor":[{"name":"Cochrane Metabolic and Endocrine Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":171,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013228","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]}}}